查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2003178

外科润滑剂市场：按类型、应用、最终用户和分销管道划分－2026-2032年全球市场预测

Surgical Lubricants Market by Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，外科润滑剂市场价值将达到 7.9268 亿美元，到 2026 年将成长至 8.7905 亿美元，到 2032 年将达到 15.8768 亿美元，年复合成长率为 10.43%。

主要市场统计数据
基准年 2025 7.9268亿美元
预计年份：2026年 8.7905亿美元
预测年份 2032 1,587,680,000 美元
复合年增长率 (%) 10.43%

权威概述，重点关注影响现代外科润滑剂选择的临床重要性、材料创新和采购考虑因素。

儘管手术润滑剂在现代临床实践中发挥着至关重要的作用，但它们的重要性却常常被低估。手术润滑剂能够确保内视镜、导管和诊断仪器的安全插入，最大限度地减少患者的不适感和手术相关併发症。聚合物化学和药物科学的进步拓展了可用润滑剂的种类，从传统的矿物油基凝胶到高性能硅油和先进的水性体系，这些润滑剂在润滑性、生物相容性和易于消毒之间取得了平衡。如今，临床医生、采购负责人和监管相关人员在评估这些产品时，不仅关注其性能，还关注其与医疗设备的兼容性、感染控制通讯协定以及患者的舒适度。

关键的变革因素正在重塑整个外科润滑剂生态系统的产品创新、临床应用和合规性重点。

在技​​术创新、临床通讯协定的不断演进以及监管审查日益严格的推动下，外科润滑剂市场正经历一系列变革。新的配方方法强调低残留水基体系和精准的硅油喷雾，这些产品仅在需要润滑的部位发挥作用，同时满足消毒和可视化的要求。同时，医疗设备设计的进步，例如微型内视镜、柔性导管和整合式感测器阵列，对润滑剂提出了更高的要求，即润滑剂必须能够维持器械的完整性，并且不会干扰成像或感测器功能。

美国于 2025 年征收的关税对营运和采购的累积影响正在推动来源多元化、区域韧性和供应链重组。

美国于2025年对进口原材料和成品征收的关税，已对整个采购、製造和分销管道造成了累积调整，并持续影响供应商的策略。严重依赖进口硅油、特殊聚合物或散装包装材料的製造商面临即时的成本压力和更长的前置作业时间，迫使他们对其采购和库存管理实践进行策略性重新评估。为此，许多供应商扩大了与国内供应商的合作关係，对替代原料进行认证，并增加了期货采购，以降低关税变化带来的风险。

详细的细分洞察，解释了产品类型、临床应用、最终用户工作流程和分销管道如何决定产品的适用性和采用率。

对产品细分的精准理解揭示了性能特征和临床工作流程如何相互作用，从而影响产品的采用。基于类型的产品区分了油基产品和硅基产品。油性产品通常配製成凝胶，适用于需要持久涂层的高润滑应用；而硅基产品则有凝胶和喷雾剂形式，与医疗设备表面具有更广泛的兼容性和更优异的热稳定性。水性配方有凝胶、啫咖哩和喷雾剂形式，可满足感染控制需求，并提供低残留性能，以满足内视镜成像过程中的可视性要求。

区域趋势和商业化策略旨在协调全球医疗保健市场的监管复杂性、临床偏好和供应链弹性。

区域趋势对监管要求、供应链选择和临床偏好产生重大影响，进而影响产品策略和商业化。在美洲，采购惯例强调建立牢固的供应商关係，遵守严格的临床应用监管标准，并满足日益增长的门诊治疗和微创手术製剂需求。面向该地区的製造商必须优先考虑文件记录、上市后监测以及及时回应医疗采购委员会的要求，以确保与医院和诊所签订合约。

公司层面的策略，结合配方创新、监管领导力以及与销售管道的伙伴关係，以确保在临床环境中得到应用和供应的确定性。

企业策略体现了产品创新、严格的监管合规和供应链管理之间的平衡。领先的供应商优先考虑配方研究和临床检验，以证明其产品与不断发展的医疗设备设计和治疗通讯协定的兼容性。他们投资于品质系统和文件记录，以应对严格的监管检查和采购审计，同时不断提高生产柔软性，以适应多种区域分销模式并应对关税带来的成本压力。

领导者可以透过结合产品创新、供应链弹性和与临床医生的合作，推动招募和营运连续性，从而采取切实可行的步骤。

产业领导者应积极整合技术、商业性和营运措施，以确保长期竞争优势。首先，他们应优先开发符合不断发展的临床通讯协定的製剂组合，投资于水性、低残留体係以及支持微创手术流程的剂型。在产品开发的同时，他们还应针对新兴医疗设备平台进行严格的相容性测试，以减少临床应用过程中的阻力，并支援采购核准。

严谨的混合方法研究设计，结合临床医师的访谈、技术检验和资料检验，得出实用且可操作的见解。

本分析的调查方法融合了关键相关人员的见解、系统性的二手文献综述以及结构化的检验，从而得出可靠的结论。主要资讯来源包括对各手术专科的临床医生、医院和门诊机构的采购经理以及监管和品管专家的访谈，他们提供了关于产品性能预期和采购标准的第一手观点。除了这些定性研究之外，还与製药科学家和医疗设备工程师进行了技术咨询，检验相容性问题和应用情境的限制。

为了改善治疗效果和采购决策，必须进行简洁的整合，强调配方和医疗设备的兼容性、供应链的灵活性以及相关人员之间的协作。

外科润滑剂融合了材料科学、临床实践和供应链管理，随着手术创伤性降低和医疗设备日益复杂，其作用必将不断扩大。配方选择、剂型以及与临床应用的相互作用决定了产品能否满足手术需求，同时确保感染控制和与医疗设备的兼容性。受关税环境和区域製造能力影响的供应链趋势持续重塑筹资策略和经营模式，凸显了整个价值链敏捷性和透明度的重要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 外科润滑剂市场：按类型划分

  • 油腻的
  • 硅基
    • 凝胶
    • 喷
  • 水溶液
    • 凝胶
    • 果冻
    • 喷

第九章 外科润滑剂市场：依应用领域划分

  • 诊断治疗
  • 内视镜检查
    • 支气管镜检查
    • 大肠镜检查
    • 胃镜检查
  • 外科手术

第十章 外科润滑剂市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 医院

第十一章 外科润滑剂市场：依通路划分

  • 在线的
  • 离线

第十二章 外科润滑剂市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 外科润滑剂市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 外科润滑剂市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国外科润滑剂市场

第十六章：中国外科润滑剂市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Ansell Limited
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • ConvaTec Group PLC
  • DeRoyal Industries, Inc.
  • Dynarex Corporation
  • Ecolab Inc.
  • Henry Schein, Inc.
  • Hollister Incorporated
  • McKesson Corporation
  • Mederi Therapeutics Inc.
  • Medline Industries, LP
  • MedSource Labs LLC
  • Medtronic plc
  • Stryker Corporation
  • Teleflex Incorporated
  • The Surety Rubber Company
Product Code: MRR-AD517FAA9D41

The Surgical Lubricants Market was valued at USD 792.68 million in 2025 and is projected to grow to USD 879.05 million in 2026, with a CAGR of 10.43%, reaching USD 1,587.68 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 792.68 million
Estimated Year [2026] USD 879.05 million
Forecast Year [2032] USD 1,587.68 million
CAGR (%) 10.43%

An authoritative introduction highlighting the clinical importance, material innovations, and procurement considerations shaping modern surgical lubricant selection

Surgical lubricants play a pivotal yet often underappreciated role in contemporary clinical practice, enabling safe insertion of endoscopes, catheters, and diagnostic devices while minimizing patient trauma and procedural complications. Advances in polymer chemistry and formulation science have expanded the range of usable agents from traditional mineral oil-based gels to high-performance silicone and advanced water-based systems that balance lubricity, biocompatibility, and ease of sterilization. Clinicians, procurement officers, and regulatory stakeholders now evaluate these products not only for performance but also for compatibility with devices, infection control protocols, and patient comfort considerations.

Consequently, clinical teams increasingly integrate product selection into procedural workflows, emphasizing formulations that reduce friction without compromising visualization or device function. Meanwhile, manufacturers focus on validation across device interfaces and regulatory pathways that prioritize safety and traceability. This introductory perspective frames the subsequent analysis by outlining the technological, clinical, and supply-side factors shaping adoption, and by highlighting the interactions between product form, application modality, and end-user requirements that determine procurement and clinical acceptance.

Key transformative forces reshaping product innovation, clinical adoption, and compliance priorities across the surgical lubricant ecosystem

The landscape for surgical lubricants is undergoing a set of transformative shifts driven by technological innovation, evolving clinical protocols, and heightened regulatory attention. New formulation approaches emphasize low-residue water-based systems and precision silicone sprays that deliver targeted lubrication while supporting sterilization and visualization requirements. At the same time, advancements in device design-smaller endoscopes, flexible catheters, and integrated sensor arrays-demand lubricants that preserve device integrity and do not interfere with imaging or sensor function.

Parallel to technological change, clinical practice patterns are shifting toward minimally invasive procedures across a broader range of indications, increasing demand for products optimized for endoscopic and ambulatory use. Regulatory frameworks and hospital procurement policies now place greater emphasis on product biocompatibility, labeling transparency, and supply chain traceability, prompting manufacturers to invest in documentation and quality systems. Together, these forces are reshaping product development priorities, clinical training protocols, and supplier relationships, with continuous innovation and compliance forming the backbone of competitive differentiation.

Cumulative operational and procurement effects of U.S. tariffs introduced in 2025 driving sourcing diversification, regional resilience, and supply-chain realignment

The introduction of tariffs affecting imported raw materials and finished goods in the United States in 2025 created a cumulative set of adjustments across procurement, manufacturing, and distribution channels that continue to influence supplier strategies. Manufacturers that relied heavily on imported silicone fluids, specialized polymers, or bulk packaging materials faced immediate cost pressures and longer lead times, prompting a strategic reevaluation of sourcing and inventory practices. In response, many suppliers expanded domestic supplier relationships, qualified alternative feedstocks, and increased forward buying to mitigate exposure to tariff volatility.

These supply-chain adjustments translated into operational trade-offs: some producers reallocated production to lower-cost facilities outside tariff-impacted supply chains, while others invested in process efficiencies to absorb additional input costs without transferring them fully to clinical buyers. Distributors and hospital procurement teams adapted by diversifying supplier panels and tightening contract terms to secure continuity. Importantly, the tariffs accelerated conversations about regional manufacturing resilience and supplier consolidation, leading to a heightened focus on transparency, dual-sourcing strategies, and nearshoring where feasible. Overall, the tariff environment catalyzed a rebalancing of cost, quality, and supply assurance priorities across the value chain.

Detailed segmentation insights explaining how formulation types, clinical applications, end-user workflows, and distribution channels determine product fit and adoption

A nuanced understanding of product segmentation clarifies how performance attributes and clinical workflows interact to shape adoption. Type-based differentiation distinguishes oil-based products, typically formulated as jelly for high-lubricity applications where long-lasting coating is desirable, from silicone-based options that appear as gel and spray formats offering compatibility with a wider range of device surfaces and favorable thermal stability. Water-based formulations, available in gel, jelly, and spray presentations, respond to infection-control preferences and offer low-residue performance that aligns with visual requirements during endoscopic imaging.

Application-focused segmentation further refines product selection by clinical context. Diagnostic procedures prioritize formulations that maintain clear visualization and reduce mucosal irritation, while surgical procedures emphasize durable lubrication that facilitates repeated instrument passes and minimizes tissue trauma. Endoscopic procedures, including bronchoscopy, colonoscopy, and gastroscopy, create distinct performance demands due to anatomical variability and device flexibility. End-user segmentation underscores operational considerations: ambulatory surgical centers and clinics often require single-use, ready-to-apply formats that support rapid turnover, while hospitals balance bulk procurement efficiencies with in-house sterilization and inventory management. Distribution channels influence accessibility and procurement workflows, with hospital pharmacies serving institutional replenishment, online sales offering direct access for specialty formulations and rapid restocking, and retail pharmacies providing point-of-care availability for outpatient and procedural clinics. Considering these intersecting segmentation dimensions reveals how formulation chemistry, delivery format, clinical application, and distribution pathways jointly determine product fit and adoption trajectories.

Regional dynamics and commercialization strategies that reconcile regulatory complexity, clinical preferences, and supply-chain resilience across global healthcare markets

Regional dynamics shape regulatory demands, supply-chain choices, and clinical preferences in ways that are consequential for product strategy and commercialization. In the Americas, procurement practices emphasize robust supplier relationships, adherence to stringent regulatory standards for clinical use, and a growing appetite for formulations that support ambulatory and minimally invasive procedures. Manufacturers targeting this region must prioritize documentation, post-market surveillance, and responsiveness to institutional buying committees to secure hospital and clinic contracts.

Overlapping regulatory frameworks and diverse healthcare infrastructures characterize Europe, Middle East & Africa, creating a complex environment where harmonized technical documentation and local regulatory expertise are critical. In this region, adoption patterns reflect both advanced tertiary care centers seeking high-performance formulations and resource-constrained settings prioritizing cost-effective, easy-to-store products. Manufacturers benefit from adaptable supply models and targeted clinical evidence to address this heterogeneity. The Asia-Pacific region combines rapid procedural volume growth with accelerated technology adoption, driving demand for scalable manufacturing, regional distribution partnerships, and products validated for a wide range of clinical settings. Across all regions, localized regulatory strategy, clinician engagement, and supply-chain resilience determine commercial success and long-term adoption.

Company-level strategies that combine formulation innovation, regulatory leadership, and channel partnerships to secure clinical adoption and supply reliability

Company strategies reflect a balance between product innovation, regulatory rigor, and supply-chain management. Leading suppliers emphasize formulation research and clinical validation to demonstrate compatibility with evolving device designs and procedural protocols. They invest in quality systems and documentation that align with stringent regulatory inspections and procurement audits, while also expanding manufacturing flexibility to serve multiple regional distribution models and address tariff-driven cost pressures.

Strategic partnerships and OEM collaborations have emerged as effective pathways to embed lubricant solutions within device ecosystems, offering bundled value propositions to hospitals and clinics. Some firms pursue focused expansion into ambulatory and outpatient channels by developing single-use, easily deployable formats and enhancing packaging for point-of-care settings. Distribution partners, including institutional pharmacies and digital channels, play an essential role in ensuring timely availability and supporting clinician education. Overall, competitive differentiation increasingly hinges on an integrated approach that combines scientific leadership, regulatory transparency, supply assurance, and targeted commercial partnerships to meet the nuanced demands of healthcare providers.

Actionable steps for leaders combining product innovation, supply-chain resilience, and clinician engagement to drive adoption and operational continuity

Industry leaders should adopt a proactive combination of technical, commercial, and operational actions to secure long-term competitive advantage. First, prioritize formulation portfolios that align with evolving clinical protocols by investing in water-based low-residue systems and delivery formats that support minimally invasive workflows. Complement product development with rigorous compatibility testing against emerging device platforms to reduce clinical adoption friction and support procurement approvals.

Second, reinforce supply-chain resilience through supplier diversification, regional manufacturing capability, and transparent traceability practices. Engage in qualified secondary sourcing for critical inputs and develop contingency inventory strategies that balance cost and service levels. Third, deepen customer engagement by offering clinician training, evidence packages, and device integration pilots that demonstrate real-world performance benefits and ease of use. Fourth, pursue strategic collaborations with device OEMs and distribution partners to create bundled solutions, streamline procurement, and accelerate adoption in ambulatory settings. Finally, align regulatory and quality investments with regional compliance requirements and post-market evidence collection to sustain trust among hospital procurement committees and clinical stakeholders. Executing these actions cohesively will position organizations to capitalize on procedural shifts while managing cost and supply risks.

A rigorous mixed-methods research design blending clinician interviews, technical validation, and data triangulation to inform practical and actionable insights

The research methodology underpinning this analysis integrates primary stakeholder insights with systematic secondary review and structured triangulation to ensure robust conclusions. Primary inputs include interviews with clinicians across procedural specialties, procurement leaders in hospitals and ambulatory settings, and regulatory and quality professionals who provide firsthand perspectives on product performance expectations and procurement criteria. These qualitative engagements were complemented by technical consultations with formulation scientists and device engineers to validate compatibility considerations and use-case constraints.

Secondary investigation drew on regulatory guidance documents, clinical procedure literature, and supply-chain reports to map material flows and compliance requirements. Data were triangulated by cross-referencing stakeholder interviews with product labeling, published clinical guidance, and distribution channel intelligence to identify consistent patterns and reconcile divergent viewpoints. Limitations include variability in institutional procurement practices and the evolving nature of regulatory guidance, which the methodology addresses through ongoing analyst validation and periodic updates to findings. Ethical standards guided all engagements, and proprietary commercial sensitivities were handled with confidentiality to preserve candid stakeholder input.

A concise synthesis emphasizing formulation-device fit, supply-chain agility, and stakeholder alignment to enhance procedural outcomes and procurement decisions

Surgical lubricants sit at the intersection of material science, clinical practice, and supply-chain management, and their role will grow as procedures become less invasive and device complexity increases. The interplay between formulation choice, delivery format, and clinical application determines how well products meet procedural demands while supporting infection control and device compatibility. Supply-chain dynamics, influenced by tariff environments and regional manufacturing capacity, continue to reshape sourcing strategies and commercial models, underscoring the need for agility and transparency across the value chain.

For decision-makers, the strategic imperative is clear: align product innovation with clinician needs, fortify supply continuity, and engage procurement stakeholders with evidence that demonstrates real-world benefits. By doing so, manufacturers and distributors can both improve procedural outcomes and create durable commercial relationships. This synthesis highlights the practical levers that stakeholders can use to respond to evolving clinical requirements and operational constraints, ensuring that lubricant selection meaningfully contributes to patient safety and procedural efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Lubricants Market, by Type

  • 8.1. Oil Based
  • 8.2. Silicone Based
    • 8.2.1. Gel
    • 8.2.2. Spray
  • 8.3. Water Based
    • 8.3.1. Gel
    • 8.3.2. Jelly
    • 8.3.3. Spray

9. Surgical Lubricants Market, by Application

  • 9.1. Diagnostic Procedures
  • 9.2. Endoscopic Procedures
    • 9.2.1. Bronchoscopy
    • 9.2.2. Colonoscopy
    • 9.2.3. Gastroscopy
  • 9.3. Surgical Procedures

10. Surgical Lubricants Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Hospitals

11. Surgical Lubricants Market, by Distribution Channel

  • 11.1. Online
  • 11.2. Offline

12. Surgical Lubricants Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Surgical Lubricants Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Surgical Lubricants Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Surgical Lubricants Market

16. China Surgical Lubricants Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Ansell Limited
  • 17.6. Baxter International Inc.
  • 17.7. Becton, Dickinson and Company
  • 17.8. Cardinal Health, Inc.
  • 17.9. ConvaTec Group PLC
  • 17.10. DeRoyal Industries, Inc.
  • 17.11. Dynarex Corporation
  • 17.12. Ecolab Inc.
  • 17.13. Henry Schein, Inc.
  • 17.14. Hollister Incorporated
  • 17.15. McKesson Corporation
  • 17.16. Mederi Therapeutics Inc.
  • 17.17. Medline Industries, LP
  • 17.18. MedSource Labs LLC
  • 17.19. Medtronic plc
  • 17.20. Stryker Corporation
  • 17.21. Teleflex Incorporated
  • 17.22. The Surety Rubber Company

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL LUBRICANTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL LUBRICANTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES SURGICAL LUBRICANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA SURGICAL LUBRICANTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY OIL BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY OIL BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY OIL BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY JELLY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY JELLY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY JELLY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY BRONCHOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY BRONCHOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY BRONCHOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY COLONOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY COLONOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY COLONOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GASTROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GASTROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GASTROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SURGICAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY SURGICAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS SURGICAL LUBRICANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. GCC SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GCC SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. GCC SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 143. GCC SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 144. GCC SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. GCC SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 146. GCC SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. GCC SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. G7 SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. G7 SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 167. G7 SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 168. G7 SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. G7 SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 170. G7 SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. G7 SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. NATO SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. NATO SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NATO SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 175. NATO SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 176. NATO SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. NATO SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 178. NATO SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. NATO SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL SURGICAL LUBRICANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES SURGICAL LUBRICANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA SURGICAL LUBRICANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA SURGICAL LUBRICANTS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA SURGICAL LUBRICANTS MARKET SIZE, BY SILICONE BASED, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA SURGICAL LUBRICANTS MARKET SIZE, BY WATER BASED, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA SURGICAL LUBRICANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA SURGICAL LUBRICANTS MARKET SIZE, BY ENDOSCOPIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA SURGICAL LUBRICANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA SURGICAL LUBRICANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)